Home » ASCO 2021

SUBSCRIBE TO NEWSLETTERS

SPECIALTIES
Meeting Coverage
DEEP DIVES
CME/CE
MEDIA & RESOURCES
SUBSCRIBE TO NEWSLETTERS
CONTRIBUTE
Follow Us

Search

Advertisement

ASCO 2021

Nivolumab, Relatlimab Combo Slows Advanced Melanoma

Nivolumab, Relatlimab Combo Slows Advanced Melanoma

May 30, 2021

Combination therapy with nivolumab and relatlimab prolongs progression-free survival compared with...

1
2

For latest news and updates

Email-id is invalid

The Company

About Physician’s Weekly

Memberships & Verifications

Work With PW

Advertise With Us

Our Policies

Terms & Conditions

Editorial Policy

Connect With PW

Follow Us

Subscribe

For latest news and updates

Email-id is invalid

The content of this site is intended for healthcare professionals.

© 2024 Physician’s Weekly

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.